Structure and cancer immunotherapy of the B7 family member B7x

Hyungjun Jeon, Vladimir Vigdorovich, Sarah C. Garrett-Thomson, Murali Janakiram, Udupi A. Ramagopal, Yael M. Abadi, Jun Sik Lee, Lisa Scandiuzzi, Kim C. Ohaegbulam, Jordan M. Chinai, Ruihua Zhao, Yu Yao, Ying Mao, Joseph A. Sparano, Steven C. Almo, Xingxing Zang

Research output: Contribution to journalArticlepeer-review

58 Scopus citations


B7x (B7-H4 or B7S1) is a member of the B7 family that can inhibit T cell function. B7x protein is absent in most normal human tissues and immune cells, but it is overexpressed in human cancers and often correlates with negative clinical outcome. The expression pattern and function of B7x suggest that it may be a potent immunosuppressive pathway in human cancers. Here, we determined the crystal structure of the human B7x immunoglobulin variable (IgV) domain at 1.59 Å resolution and mapped the epitopes recognized by monoclonal antibodies. We developed an in vivo system to screen therapeutic monoclonal antibodies against B7x and found that the clone 1H3 significantly inhibited growth of B7xexpressing tumors in vivo via multiple mechanisms. Furthermore, the surviving mice given 1H3 treatment were resistant to tumor rechallenge. Our data suggest that targeting B7x on tumors is a promising cancer immunotherapy and humanized 1H3 may be efficacious for immunotherapy of human cancers.

Original languageEnglish (US)
Pages (from-to)1089-1098
Number of pages10
JournalCell Reports
Issue number3
StatePublished - 2014

ASJC Scopus subject areas

  • General Biochemistry, Genetics and Molecular Biology


Dive into the research topics of 'Structure and cancer immunotherapy of the B7 family member B7x'. Together they form a unique fingerprint.

Cite this